Growth Metrics

Mannkind (MNKD) Non-cash Items (2011 - 2026)

Mannkind (MNKD) reported Non-cash Items of $4.5 million for Q1 2026, down 79.26% on a QoQ basis from $21.5 million in Q4 2025.

Mannkind (MNKD) has 16 years of Non-cash Items data on file, last reported at $4.5 million in Q1 2026.

  • Quarterly Non-cash Items changed N/A year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (changed N/A YoY) and the FY2025 annual result came in at $5.0 million, down 26.49% from the prior year.
  • Non-cash Items declined to $4.5 million in Q1 2026 per MNKD's latest filing, from $21.5 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $32.4 million in Q4 2024 and bottomed at $200000.0 in Q2 2023.
  • The 5-year median for Non-cash Items is $3.0 million (2022), against an average of $10.8 million.
  • The widest annual swing landed in 2022, when Non-cash Items surged 200.0%; it then tumbled 87.5% in 2023.
  • Tracing MNKD's Non-cash Items over 5 years: stood at $29.5 million in 2022, then tumbled by 48.65% to $15.2 million in 2023, then jumped by 114.07% to $32.4 million in 2024, then plunged by 33.65% to $21.5 million in 2025, then sank by 79.26% to $4.5 million in 2026.
  • Per Business Quant, the three latest MNKD Non-cash Items figures stand at $4.5 million (Q1 2026), $21.5 million (Q4 2025), and $32.4 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.46 Mn
Mar 31, 2026 4.46 Mn
Dec 31, 2025 21.52 Mn
Dec 31, 2025 21.52 Mn
Dec 31, 2024 32.44 Mn
Dec 31, 2024 32.44 Mn
Dec 31, 2023 15.15 Mn
Dec 31, 2023 15.15 Mn
Jun 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 400,000.00
Mar 31, 2023 400,000.00
Dec 31, 2022 29.51 Mn
Dec 31, 2022 29.51 Mn
Sep 30, 2022 900,000.00
Sep 30, 2022 900,000.00
Jun 30, 2022 1.60 Mn
Jun 30, 2022 1.60 Mn
Mar 31, 2022 1.50 Mn
Mar 31, 2022 1.50 Mn
Dec 31, 2021 34.54 Mn
Dec 31, 2021 34.54 Mn
Sep 30, 2021 300,000.00
Sep 30, 2021 300,000.00
Jun 30, 2021 3.40 Mn
Jun 30, 2021 3.40 Mn
Mar 31, 2021 4.10 Mn
Mar 31, 2021 4.10 Mn
Dec 31, 2020 15.41 Mn
Dec 31, 2020 15.41 Mn
Sep 30, 2020 5.60 Mn
Sep 30, 2020 5.60 Mn
Jun 30, 2020 6.80 Mn
Jun 30, 2020 6.80 Mn
Mar 31, 2020 8.00 Mn
Mar 31, 2020 8.00 Mn
Dec 31, 2019 182,000.00
Dec 31, 2019 182,000.00
Sep 30, 2019 11.10 Mn
Sep 30, 2019 11.10 Mn
Jun 30, 2019 12.50 Mn
Jun 30, 2019 12.50 Mn
Mar 31, 2019 8.60 Mn
Mar 31, 2019 8.60 Mn
Dec 31, 2018 3.67 Mn
Dec 31, 2018 3.67 Mn
Sep 30, 2018 8.60 Mn
Sep 30, 2018 8.60 Mn
Jun 30, 2018 2.00 Mn
Jun 30, 2018 2.00 Mn
Mar 31, 2018 3.40 Mn
Mar 31, 2018 3.40 Mn
Dec 31, 2017 2.81 Mn
Dec 31, 2017 2.81 Mn
Sep 30, 2017 3.20 Mn
Sep 30, 2017 3.20 Mn
Jun 30, 2017 3.90 Mn
Jun 30, 2017 3.90 Mn
Mar 31, 2017 100,000.00
Mar 31, 2017 100,000.00
Dec 31, 2016 3.41 Mn
Dec 31, 2016 3.41 Mn
Sep 30, 2016 5.00 Mn
Sep 30, 2016 5.00 Mn
Jun 30, 2016 5.60 Mn
Jun 30, 2016 5.60 Mn
Dec 31, 2015 17.22 Mn
Dec 31, 2015 17.22 Mn
Dec 31, 2014 33.50 Mn
Dec 31, 2014 33.50 Mn
Dec 31, 2013 40.97 Mn
Dec 31, 2013 40.97 Mn
Dec 31, 2012 4.87 Mn
Dec 31, 2012 4.87 Mn
Dec 31, 2011 168.00
Dec 31, 2011 168.00